Current Neuropharmacology

Graphical Abstract
pp. i-iii(3)

Meet Our Editorial Board Member
pp. 107-107(1)
Author: Aldenkamp, Albert P.

Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
pp. 108-128(21)
Authors: Hamill, Jonathan; Hallak, Jaime; Dursun, Serdar M.; Baker, Glen

Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
pp. 129-141(13)
Authors: Vega-Riquer, Jose M.; Mendez-Victoriano, Gerardo; Morales-Luckie, Raul A.; Gonzalez-Perez, Oscar

The Role of CXCR3 in Neurological Diseases
pp. 142-150(9)
Authors: Zhou, Ya-Qun; Liu, Dai-Qiang; Chen, Shu-Ping; Sun, Jia; Zhou, Xue-Rong; Xing, Cui; Ye, Da-Wei; Tian, Yu-Ke

Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance
pp. 151-164(14)
Authors: Taş, Yağmur Çetin; Solaroğlu, İhsan; Gürsoy-Özdemir, Yasemin

Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review
pp. 165-175(11)
Authors: Jamwal, Sumit; Kumar, Puneet

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
pp. 176-183(8)
Authors: Talarico, Giuseppina; Trebbastoni, Alessandro; Bruno, Giuseppe; de Lena, Carlo

Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
pp. 184-196(13)
Authors: Hu, Lang-Yue; Mi, Wen-Li; Wu, Gen-Cheng; Wang, Yan-Qing; Mao-Ying, Qi-Liang